Ensysce Biosciences Inc —— 资产负债表 (NASDAQ:ENSC) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 12.85 M16.42 M5.89 M2.71 M5.6 M7.45 M 负债总额 7.8 M24.58 M9.91 M3.36 M2.22 M4.57 M 权益总额 5 M-8.16 M-4.03 M-651.27 K3.38 M2.88 M 负债及股东权益总额 12.85 M16.42 M5.89 M2.71 M5.6 M7.45 M 总债务 225 K20.84 M4.72 M854.7 K—— 净债务 175.8 K8.58 M1.57 M-268.91 K——

新闻

Ensysce公布限制阿片类药物过量技术的一期临床数据

Ensysce publishes phase 1 data on overdose-limiting opioid tech

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.05%

美国股市收低；截至收盘道琼斯工业平均指数下跌1.05%

Tiny Pain-Focused Biotech Ensysce Biosciences Surges Amid Strategic Review - Ensysce Biosciences (NASDAQ:ENSC)

Ensysce Biosciences在3期疼痛药物试验中达到50%入组率

Ensysce Biosciences reaches 50% enrollment in Phase 3 pain drug trial

Ensysce Biosciences在巴西获得疼痛技术专利授权

Ensysce Biosciences receives patent allowance in Brazil for pain tech

Ensysce Biosciences, Inc. (ENSC) Shareholder/Analyst Call Prepared Remarks Transcript

Ensysce Biosciences advances phase 3 trial for abuse-resistant opioid

Ensysce Biosciences enrolls first patient in phase 3 pain drug trial